ALVO Stock Summary and Trading Ideas (Alvotech - | NASDAQ:ALVO)

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Alvotech - trades on the NASDAQ stock market under the symbol ALVO.

As of January 14, 2025, ALVO stock price climbed to $13.40 with 27,584 million shares trading.

ALVO has a beta of 0.52, meaning it tends to be less sensitive to market movements. ALVO has a correlation of 0.02 to the broad based SPY ETF.

ALVO has a market cap of $4.05 billion. This is considered a Mid Cap stock.

Last quarter Alvotech - reported $103 million in Revenue and -$.02 earnings per share. This beat revenue expectation by $14 million and exceeded earnings estimates by $.04.

The top ETF exchange traded funds that ALVO belongs to (by Net Assets): IBB, ONEQ, BIB, IBBQ, STXK.

ALVO has underperformed the market in the last year with a return of +8.9%, while SPY returned +24.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ALVO shares. However, ALVO has outperformed the market in the last 3 month and 2 week periods, returning +7.6% and +2.9%, while SPY returned +1.1% and -0.7%, respectively. This indicates ALVO has been having a stronger performance recently.

ALVO support price is $12.94 and resistance is $13.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALVO shares will trade within this expected range on the day.